Drug Combination Details
General Information of the Combination (ID: C76406) | |||||
---|---|---|---|---|---|
Name | Acteoside + Paeoniflorin | + | X-ray irradiation | ||
Click to Show/Hide the Each NP or Drug Information of This Combination | |||||
Name | Acteoside NP Info | Drug Info | |||
Structure |
![]() |
![]() |
|||
Name | Paeoniflorin NP Info | ||||
Structure |
![]() |
![]() |
|||
Disease |
Healthy individual
[ICD-11: N.A.]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Decreasing Adverse Drug Reaction by This Combination | ||||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | CASP3 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | Human skin fibroblasts | Healthy | Homo sapiens | |||
Experimental
Result(s) |
Acteoside could protect the cells from X ray induced damage through enhancing the scavenging activity of ROS, decreasing the Bax/Bcl 2 ratio and downregulating the activity of procaspase 3, as well as modulating the mitogen activated protein kinase signaling pathways. |
References | ||||
---|---|---|---|---|
Reference 1 | Protective effects of acteoside against X?ray?induced damage in human skin fibroblasts. Mol Med Rep. 2015 Aug;12(2):2301-6. |


